within Pharmacolibrary.Drugs.ATC.P;

model P03BX06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Etohexadiol (6,6-dihydroxy-2,4-hexadiene) is an aliphatic alcohol formerly used as an ectoparasiticide and insect repellent, particularly for the control of head lice and mosquitoes. Etohexadiol is no longer approved for human use due to toxicity concerns, primarily neurotoxicity and developmental toxicity identified in animal studies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for etohexadiol have not been reported in existing peer-reviewed literature or public pharmacokinetic databases for humans, likely due to discontinued clinical use and safety concerns.</p><h4>References</h4><ol><li>Alexander N Shikov, Elena V Flisyuk, Ekaterina D Obluchinskaya, Olga N Pozharitskaya,Pharmacokinetics of Marine-Derived Drugs.,Marine drugs,2020<a href='https://pubmed.ncbi.nlm.nih.gov/33182407/'>https://pubmed.ncbi.nlm.nih.gov/33182407/</a></li><li>Hannah Katharine Batchelor, John Francis Marriott,Paediatric pharmacokinetics: key considerations.,British journal of clinical pharmacology,2015<a href='https://pubmed.ncbi.nlm.nih.gov/25855821/'>https://pubmed.ncbi.nlm.nih.gov/25855821/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end P03BX06;
